Study for blood metabolomics of patients after laparoscopic colorectal cancer surgery with Xiangbin prescription

ABSTRACT: Interventions: Group 1:Routine therapy plus Xiangbin prescription for patients with colorectal cancer (preoperative + postoperative);Group 2:Routine therapy plus placebo for patients with colorectal cancer (preoperative + postoperative);Healthy person:No Intervention Primary outcome(s): Small Molecular Metabolomics of Blood Study Design: Non randomized control

DISEASE(S): Colorectal Cancer

PROVIDER: 2682122 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR